Ubuhlungu Beqolo Obungamahlalakhona: Ukwelashwa Okusha Okusha Kwangempela Kwangempela

I-QUICKPOST 1 | eTurboNews | eTN
Ibhalwe ngu Linda Hohnholz

I-AppliedVR, iphayona elithuthukisa isizukulwane esilandelayo sezokwelapha ezicwilisayo, namuhla umemezele ukuthi i-US Food and Drug Administration (FDA) inikeze imvume ka-de novo nge-flagship immersive therapy, i-EaseVRx, yokwelapha ubuhlungu obungapheli obuphansi emuva, obuthole ukuqokwa kwedivayisi okuphumelelayo. ngo-2020. Lezi zindaba zifika futhi ezithendeni ze-AppliedVR imemezela umjikelezo wayo woxhaso lwezigidi ezingu-36 zamaRandi, okwenza uxhaso lwayo luphelele lube ngamaRandi ayizigidi ezingu-71.

I-EaseVRx iyidivayisi yezokwelapha esebenzisa incwadi kadokotela enokuqukethwe kwesofthiwe elayishwe ngaphambili kunkundla yezingxenyekazi zekhompuyutha eziphathelene nokunikeza ukuqeqeshwa kokulawula ubuhlungu ngokusekelwe kumakhono okuziphatha kwengqondo nezinye izindlela zokuziphatha. Isebenzisa isistimu ye-immersive virtual reality (VR) eletha okuqukethwe kwe-VR kuyilapho ihlanganisa imfundo yobuhlungu be-biopsychosocial, ukuqeqeshwa kokuphefumula kwe-diaphragmatic, ukuvivinya ingqondo, ukuvivinya umzimba kokuphendula ukuphumula kanye nemidlalo yokusebenza ephezulu.

Okuqukethwe kwesofthiwe ye-EaseVRx kuhlanganisa amaviki ayisishiyagalombili, uhlelo olusekelwe ku-VR olusiza abantu behlise ubunzima bezimpawu kanye nomthelela wobuhlungu babo. Abantu abanobuhlungu obungapheli bokubuyela emuva balandela uhlelo oluqinisekisiwe emtholampilo, olusekelwe ebufakazini ukuze bathuthukise amakhono okubhekana nesimo ngenkathi futhi bedala imikhuba emisha, ewusizo enganciphisa ubuhlungu obukhulu nokuphazamiseka kobuhlungu.

"Imvume ye-FDA yanamuhla iphawula usuku olukhulu lwe-AppliedVR, emkhakheni wezokwelapha ogxile kakhulu futhi, okubaluleke kakhulu, kulabo bantu abanobuhlungu obungapheli bomgogodla," kusho uMatthew Stoudt, umsunguli kanye ne-CEO ye-AppliedVR. “Ubuhlungu obungapheli bokubuyela emuva bungaba yinkinga ethena amandla futhi ebize ngendlela emangalisayo, kodwa manje sesisondele ekufinyeleleni umgomo wethu wokwenza izindlela zokwelapha ezigxilile zibe izinga lokunakekela izinhlungu.”

Ukuhanjiswa kwe-FDA ye-AppliedVR kwasekelwa izivivinyo ezimbili ezilawulwa ngokungahleliwe (RCTs), ezihlola ukuphumelela kohlelo olusekelwe ku-VR lokuzilapha ngokwakho ubuhlungu obungapheli ekhaya. Zombili izifundo zaphetha ngokuthi uhlelo lokwelapha lwe-VR oluzilawulayo, olusekelwe kumakhono lwalungeyona nje indlela engenzeka futhi eyingozi yokwelapha ubuhlungu obungapheli, futhi lwalusebenza kahle ekuthuthukiseni imiphumela eminingi yobuhlungu obungapheli.

Ucwaningo lokuqala, olushicilelwe ku-JMIR Formative Research, luhlaziye idatha evela kubantu abahlukunyezwa ubuhlungu obungapheli obuphansi noma be-fibromyalgia phakathi nenkathi yezinsuku ezingu-21. Ababambiqhaza abasebenzisa i-EaseVRx banciphise kakhulu izinkomba ezinhlanu zobuhlungu eziyinhloko - ngayinye eyahlangabezana noma yadlula umkhawulo we-30-percent ukuze ube nenjongo yomtholampilo.

Ku-RCT yayo ebalulekile efunda ukuphepha nokusebenza kwe-EaseVRx esikhathini esingamaviki ayisishiyagalombili, ababambiqhaza eqenjini le-EaseVRx ngokwesilinganiso babike intuthuko enkulu ngemva kokwelashwa, okuhlanganisa ukuncishiswa kwe-42% kokuqina kobuhlungu; 49% ukunciphisa ukuphazamiseka komsebenzi; 52% ukunciphisa ukuphazamiseka kokulala; 56% ukunciphisa ukuphazamiseka kwemizwelo; kanye nokunciphisa okungama-57% kokuphazanyiswa kwengcindezi.

Idatha yokuzibandakanya neyokusetshenziswa ibalulekile kubahlinzeki nakubakhokhi okufanele bahlole ukuthi amalungu/iziguli zizosebenzisa indlela yokwelapha yedijithali — ikakhulukazi kuzona ngaphandle kwezilungiselelo zomtholampilo. Ocwaningweni olubalulekile, ababambiqhaza be-EaseVRx babonise ukuzibandakanya okuphezulu ngesilinganiso sokuqedwa kwamaseshini angu-5.4 ngeviki futhi babonisa ukwaneliseka kalula ekusebenziseni Isikali Sokusetshenziswa Kwesistimu (ukulinganisa idivayisi kulula ukuyisebenzisa kune-ATM namasevisi e-imeyili aphezulu).

"Sisebenze ngokuzikhandla kule minyaka embalwa edlule ukwakha indikimba yobufakazi bomtholampilo obungenakuqhathaniswa obubonisa amandla e-VR ekwelapheni izinhlungu, futhi asikwazanga ukujabula kakhulu ukufeza lesi sigameko esibalulekile," kusho uJosh Sackman, i-AppliedVR co- umsunguli nomongameli. “Kodwa-ke, umsebenzi wethu awumi ngale mvume eyodwa. Sizibophezele ekuqhubekeni nocwaningo oluqinisekisa ukusebenza kahle kwethu kanye nokusebenza ngempumelelo kwezindleko ekwelapheni ubuhlungu obungapheli nezinye izinkomba.”

Ubuhlungu obuphansi emuva bungesinye sezimo ezivamile ezingapheli abantu ababhekana nazo emhlabeni wonke futhi simelela esinye sezizathu eziphezulu ezenza abantu baphuthelwe umsebenzi. Ukwengeza, kuyinkinga ebiza kakhulu kubadayisi bomshwalense njengoba abaningi bebheka ukunciphisa izindleko ezihlobene nokuhlinzwa emuva. Ucwaningo lwakamuva lubonise ukuthi, lapho kuhlangene nobuhlungu bentamo, ubuhlungu obuphansi emuva bubiza cishe amaRandi ayizigidi eziyizinkulungwane ezingu-77 kumshwalense wangasese, amaRandi ayizigidi eziyizinkulungwane ezingu-45 kumshwalense womphakathi, kanye namaRandi ayizigidi eziyizinkulungwane ezingu-12 ezindlekweni eziphuma ephaketheni ezigulini.

Ubuhlungu obungapheli, ngokubanzi, buyabiza futhi bunomthelela kwezinye izinkinga zezempilo, kuhlanganise nobhubhane lwe-opioid. Ucwaningo lwangaphambili lukaJohns Hopkins ku-Journal of Pain luthole ukuthi ubuhlungu obungapheli bungabiza imali efinyelela ku-$ 635 billion ngonyaka - ngaphezu kwezindleko zonyaka zomdlavuza, isifo senhliziyo nesifo sikashukela kuhlangene.

"Ubuhlungu buvame ukuphathwa ngendlela ye-biomedical kuphela ngezici ezibalulekile zobuhlungu obushiywe bungelashwa," kusho uDkt. Beth Darnall, umeluleki omkhulu wesayensi ye-AppliedVR kanye nososayensi wezinhlungu waseStanford. “Ucwaningo lwethu lubonisa ukuthi i-VR ingakala ukunakekelwa okuphumelelayo kwezinhlungu ezingapheli 'zomuntu wonke' abantu abangazisebenzisa kalula ekunethezekeni kwekhaya labo. Njengomholi wesigaba sezokwelapha ezigxilile, i-AppliedVR manje isisendaweni engcono kakhulu yokuhambisa ushintsho olubheke ekunakekelweni kwezinhlungu okufinyelelekayo. "

Ngemva kokugunyazwa kwayo kokuqala kwe-FDA, i-AppliedVR ihlela ukuqhubeka nokuhlola ukuze ibonise ukusebenza ngempumelelo komtholampilo kanye nokusebenza kahle kwezindleko zokusebenzisa i-VR ukwelapha izinhlungu, okuphawuleka kakhulu ukuphothula izifundo eziningi zezomnotho nemiphumela yezempilo (HEOR) nabakhokhi bezentengiselwano. I-AppliedVR nayo njengamanje isebenzisana ne-Geisinger kanye ne-Cleveland Clinic ukuze kuthuthukiswe izivivinyo zomtholampilo ezihlukene ezixhaswe yi-NIDA ezihlola i-VR njengethuluzi elisindisa i-opioid lobuhlungu obukhulu nobungamahlalakhona.

I-AppliedVR isivele yethenjwa yizinhlelo zezempilo ezihamba phambili ezingaphezu kuka-200 emhlabeni. Ubuchwepheshe busetshenziswe cishe iziguli ze-60,000 kuze kube manje ekulawuleni ubuhlungu kanye nezinhlelo zempilo.

<

Mayelana umbhali

Linda Hohnholz

Umhleli omkhulu we eTurboNews ezinze eTN HQ.

Bhalisa
Yazisa ngakho
isivakashi
0 Amazwana
Okungaphakathi Okuphakelayo
Buka wonke amazwana
0
Ungathanda imibono yakho, ngicela uphawule.x
Yabelana ku...